EI
Endogenex, Inc.
SEC filingOther Health Care · Plymouth, MN
Amount raised$132.4Msold at filing
Total offering$144.6M$12.2M still open
Investors in the raise16count reported to the SEC
FiledNov 6, 2026first sale Jun 13, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Stacey PughExecutive Officer, Director
Juliet BakkerDirector
Gerald BrunkDirector
James EadieDirector
Doug ReedDirector
Thomas ShehabDirector
Krissy WrightExecutive Officer
Executive officers, directors and promoters as listed on the Form D.